Bleeding Hazard of Percutaneous Tracheostomy in COVID-19 Patients Supported With Venovenous Extracorporeal Membrane Oxygenation: A Case Series
Authors' conclusion
In this case series, percutaneous tracheostomy during VV-ECMO in patients with COVID-19 appeared to be safe and did not pose additional risks to patients or healthcare workers.
Study context
- Population
- Patients on VV-ECMO undergoing bedside percutaneous tracheostomy, tertiary university-affiliated national ECMO centre
- Participants
- 16 vs 16
- Exposure
- COVID-19 vs Non-COVID-19
- COVID-19n = 16
- Non-COVID-19n = 16reference
- Outcome
- Moderate-to-severe bleeding
Methodological detailssingle-centre, comparison with non-COVID-19 patients
- Single-centre
- Comparison with non-COVID-19 patients
Main finding
As reported in the abstract
- Moderate-to-severe bleeding similar in both groups
Observational data: associations, not effects.
Further findings
30- and 90-day mortality
- No difference in 30- and 90-day mortality between groups
Staff COVID-19 infection
- No staff involved contracted COVID-19 (routine screening)
Safety
Life-threatening procedural complication · 48 hours
- No patient had a life-threatening procedural complication
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Bleeding Hazard of Percutaneous Tracheostomy in COVID-19 Patients Supported With Venovenous Extracorporeal Membrane Oxygenation: A Case Series. J Cardiothorac Vasc Anesth. Published 20 September 2022. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →